Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90
U.S. Physical Therapy
U.S. Physical Therapy USPH | 0.00 |
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:
USPH) with a Outperform and lowers the price target from $103 to $90.